{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:29:35Z","timestamp":1790713775168,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In Gaucher disease (GD), resulting from mutations in the GBA gene, mutant \u03b2-glucocerebrosidase (GCase) molecules are recognized as misfolded in the endoplasmic reticulum (ER). They are retrotranslocated to the cytoplasm, where they are ubiquitinated and undergo proteasomal degradation in a process known as the ER Associated Degradation (ERAD). We have shown in the past that the degree of ERAD of mutant GCase correlates with GD severity.<\/jats:p>\n            <jats:p>Persistent presence of mutant, misfolded protein molecules in the ER leads to ER stress and evokes the unfolded protein response (UPR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We investigated the presence of UPR in several GD models, using molecular and behavioral assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our results show the existence of UPR in skin fibroblasts from GD patients and carriers of GD mutations. We could recapitulate UPR in two different <jats:italic>Drosophila<\/jats:italic> models for carriers of GD mutations: flies heterozygous for the endogenous mutant GBA orthologs and flies expressing the human N370S or L444P mutant GCase variants. We encountered early death in both fly models, indicating the deleterious effect of mutant GCase during development. The double heterozygous flies, and the transgenic flies, expressing mutant GCase in dopaminergic\/serotonergic cells developed locomotion deficit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results strongly suggest that mutant GCase induces the UPR in GD patients as well as in carriers of GD mutations and leads to development of locomotion deficit in flies heterozygous for GD mutations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-1172-8-140","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T11:48:02Z","timestamp":1378900082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Unfolded protein response in Gaucher disease: from human to Drosophila"],"prefix":"10.1186","volume":"8","author":[{"given":"Gali","family":"Maor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigal","family":"Rencus-Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Filocamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Steller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,11]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6","volume":"8","author":"E Beutler","year":"1996","unstructured":"Beutler E, Gelbart T: Glucocerebrosidase (Gaucher disease). Hum Mutat. 1996, 8: 207-213.","journal-title":"Hum Mutat"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","volume":"129","author":"M Jmoudiak","year":"2005","unstructured":"Jmoudiak M, Futerman AH: Gaucher disease: pathological mechanisms and modern management. Br J Haematol. 2005, 129: 178-188.","journal-title":"Br J Haematol"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska KS, LaMarca ME, Scott CR, Sidransky E: Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008, 29: 567-583.","journal-title":"Hum Mutat"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1073\/pnas.85.7.2349","volume":"85","author":"S Tsuji","year":"1988","unstructured":"Tsuji S, Martin BM, Barranger JA, Stubblefield BK, LaMarca ME, Ginns EI: Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc Natl Acad Sci USA. 1988, 85: 2349-2352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"664_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJM198703053161002","volume":"316","author":"S Tsuji","year":"1987","unstructured":"Tsuji S, Choudary PV, Martin BM, Stubblefield BK, Mayor JA, Barranger JA, Ginns EI: A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher\u2019s disease. N Engl J Med. 1987, 316: 570-575.","journal-title":"N Engl J Med"},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1073\/pnas.88.23.10544","volume":"88","author":"E Beutler","year":"1991","unstructured":"Beutler E, Gelbart T, Kuhl W, Sorge J, West C: Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci USA. 1991, 88: 10544-10547.","journal-title":"Proc Natl Acad Sci USA"},{"key":"664_CR7","doi-asserted-by":"crossref","first-page":"14319","DOI":"10.1016\/S0021-9258(17)38720-3","volume":"260","author":"AH Erickson","year":"1985","unstructured":"Erickson AH, Ginns EI, Barranger JA: Biosynthesis of the lysosomal enzyme glucocerebrosidase. J Biol Chem. 1985, 260: 14319-14324.","journal-title":"J Biol Chem"},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"R622","DOI":"10.1016\/j.cub.2012.07.004","volume":"22","author":"SS Cao","year":"2012","unstructured":"Cao SS, Kaufman RJ: Unfolded protein response. Curr Biol. 2012, 22: R622-R626.","journal-title":"Curr Biol"},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","volume":"334","author":"P Walter","year":"2011","unstructured":"Walter P, Ron D: The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011, 334: 1081-1086.","journal-title":"Science"},{"key":"664_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1385\/MB:34:2:279","volume":"34","author":"M Schroder","year":"2006","unstructured":"Schroder M: The unfolded protein response. Mol Biotechnol. 2006, 34: 279-290.","journal-title":"Mol Biotechnol"},{"issue":"Suppl 2","key":"664_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1463-1326.2010.01281.x","volume":"12","author":"RJ Kaufman","year":"2010","unstructured":"Kaufman RJ, Back SH, Song B, Han J, Hassler J: The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in beta-cells. Diabetes Obes Metab. 2010, 12 (Suppl 2): 99-107.","journal-title":"Diabetes Obes Metab"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/cddis.2011.31","volume":"2","author":"N Badiola","year":"2011","unstructured":"Badiola N, Penas C, Minano-Molina A, Barneda-Zahonero B, Fado R, Sanchez-Opazo G, Comella JX, Sabria J, Zhu C, Blomgren K, et al: Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12. Cell Death Dis. 2011, 2: e149.","journal-title":"Cell Death Dis"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1051\/medsci\/2007233291","volume":"23","author":"F Foufelle","year":"2007","unstructured":"Foufelle F, Ferre P: [Unfolded protein response: its role in physiology and physiopathology]. Med Sci (Paris). 2007, 23: 291-296.","journal-title":"Med Sci (Paris)"},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/B978-0-12-386033-0.00005-0","volume":"292","author":"R Benyair","year":"2011","unstructured":"Benyair R, Ron E, Lederkremer GZ: Protein quality control, retention, and degradation at the endoplasmic reticulum. Int Rev Cell Mol Biol. 2011, 292: 197-280.","journal-title":"Int Rev Cell Mol Biol"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2005.09.036","volume":"123","author":"S Janssens","year":"2005","unstructured":"Janssens S, Tinel A, Lippens S, Tschopp J: PIDD mediates NF-kappaB activation in response to DNA damage. Cell. 2005, 123: 1079-1092.","journal-title":"Cell"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1083\/jcb.201110131","volume":"197","author":"S Wang","year":"2012","unstructured":"Wang S, Kaufman RJ: The impact of the unfolded protein response on human disease. J Cell Biol. 2012, 197: 857-867.","journal-title":"J Cell Biol"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/hmg\/ddm324","volume":"17","author":"H Wei","year":"2008","unstructured":"Wei H, Kim SJ, Zhang Z, Tsai PC, Wisniewski KE, Mukherjee AB: ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum Mol Genet. 2008, 17: 469-477.","journal-title":"Hum Mol Genet"},{"key":"664_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbrc.2011.08.080","volume":"413","author":"YJ Lee","year":"2011","unstructured":"Lee YJ, Kim SJ, Heo TH: Protective effect of catechin in type I Gaucher disease cells by reducing endoplasmic reticulum stress. Biochem Biophys Res Commun. 2011, 413: 254-258.","journal-title":"Biochem Biophys Res Commun"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","volume":"18","author":"T Farfel-Becker","year":"2009","unstructured":"Farfel-Becker T, Vitner E, Dekel H, Leshem N, Enquist IB, Karlsson S, Futerman AH: No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Hum Mol Genet. 2009, 18: 1482-1488.","journal-title":"Hum Mol Genet"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","volume":"19","author":"I Ron","year":"2010","unstructured":"Ron I, Rapaport D, Horowitz M: Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease. Hum Mol Genet. 2010, 19: 3771-3781.","journal-title":"Hum Mol Genet"},{"key":"664_CR21","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","volume":"14","author":"I Ron","year":"2005","unstructured":"Ron I, Horowitz M: ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum Mol Genet. 2005, 14: 2387-2398.","journal-title":"Hum Mol Genet"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bcmd.2005.03.006","volume":"35","author":"I Ron","year":"2005","unstructured":"Ron I, Dagan A, Gatt S, Pasmanik-Chor M, Horowitz M: Use of fluorescent substrates for characterization of Gaucher disease mutations. Blood Cells Mol Dis. 2005, 35: 57-65.","journal-title":"Blood Cells Mol Dis"},{"key":"664_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/humu.22124","volume":"33","author":"I Bendikov-Bar","year":"2012","unstructured":"Bendikov-Bar I, Horowitz M: Gaucher disease paradigm: from ERAD to co-morbidity. Hum Mutat. 2012, 33: 1398-1407.","journal-title":"Hum Mutat"},{"key":"664_CR24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","volume":"134","author":"TW Mu","year":"2008","unstructured":"Mu TW, Ong DS, Wang YJ, Balch WE, Yates JR, Segatori L, Kelly JW: Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell. 2008, 134: 769-781.","journal-title":"Cell"},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4161\/cc.7.7.5615","volume":"7","author":"EL Davenport","year":"2008","unstructured":"Davenport EL, Morgan GJ, Davies FE: Untangling the unfolded protein response. Cell Cycle. 2008, 7: 865-869.","journal-title":"Cell Cycle"},{"key":"664_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/oxfordjournals.jbchem.a124284","volume":"115","author":"N Sasagasako","year":"1994","unstructured":"Sasagasako N, Kobayashi T, Yamaguchi Y, Shinnoh N, Goto I: Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity. J Biochem. 1994, 115: 113-119.","journal-title":"J Biochem"},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2007.12.017","volume":"132","author":"D Ron","year":"2008","unstructured":"Ron D, Hubbard SR: How IRE1 reacts to ER stress. Cell. 2008, 132: 24-26.","journal-title":"Cell"},{"key":"664_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12192-011-0306-2","volume":"17","author":"A van Schadewijk","year":"2012","unstructured":"van Schadewijk A, Van\u2019t Wout EF, Stolk J, Hiemstra PS: A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress. Cell Stress Chaperones. 2012, 17: 275-279.","journal-title":"Cell Stress Chaperones"},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","volume":"46","author":"I Bendikov-Bar","year":"2011","unstructured":"Bendikov-Bar I, Ron I, Filocamo M, Horowitz M: Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant. Blood Cells Mol Dis. 2011, 46: 4-10.","journal-title":"Blood Cells Mol Dis"},{"key":"664_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ymgme.2007.10.132","volume":"93","author":"I Ron","year":"2008","unstructured":"Ron I, Horowitz M: Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients. Mol Genet Metab. 2008, 93: 426-436.","journal-title":"Mol Genet Metab"},{"key":"664_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/mgme.2001.3201","volume":"73","author":"N Tayebi","year":"2001","unstructured":"Tayebi N, Callahan M, Madike V, Stubblefield BK, Orvisky E, Krasnewich D, Fillano JJ, Sidransky E: Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab. 2001, 73: 313-321.","journal-title":"Mol Genet Metab"},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K, Rosenbaum H, Schiffmann R, Bembi B, Sidransky E: Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?. Mol Genet Metab. 2003, 79: 104-109.","journal-title":"Mol Genet Metab"},{"key":"664_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ajmg.a.10028","volume":"116A","author":"J Varkonyi","year":"2003","unstructured":"Varkonyi J, Rosenbaum H, Baumann N, MacKenzie JJ, Simon Z, Aharon-Peretz J, Walker JM, Tayebi N, Sidransky E: Gaucher disease associated with parkinsonism: four further case reports. Am J Med Genet A. 2003, 116A: 348-351.","journal-title":"Am J Med Genet A"},{"key":"664_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.WNL.0000072482.70963.D7","volume":"61","author":"B Bembi","year":"2003","unstructured":"Bembi B, Zambito Marsala S, Sidransky E, Ciana G, Carrozzi M, Zorzon M, Martini C, Gioulis M, Pittis MG, Capus L: Gaucher\u2019s disease with Parkinson\u2019s disease: clinical and pathological aspects. Neurology. 2003, 61: 99-101.","journal-title":"Neurology"},{"key":"664_CR35","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R: Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med. 2004, 351: 1972-1977.","journal-title":"N Engl J Med"},{"key":"664_CR36","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jmg.2004.024455","volume":"41","author":"O Goker-Alpan","year":"2004","unstructured":"Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E: Parkinsonism among Gaucher disease carriers. J Med Genet. 2004, 41: 937-940.","journal-title":"J Med Genet"},{"key":"664_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E: Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab. 2004, 81: 70-73.","journal-title":"Mol Genet Metab"},{"key":"664_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/mds.20320","volume":"20","author":"LN Clark","year":"2005","unstructured":"Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, et al: Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson\u2019s disease in subjects of Jewish ethnicity. Mov Disord. 2005, 20: 100-103.","journal-title":"Mov Disord"},{"key":"664_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJM200502173520719","volume":"352","author":"MJ Eblan","year":"2005","unstructured":"Eblan MJ, Walker JM, Sidransky E: The glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med. 2005, 352: 728-731. author reply 728\u2013731.","journal-title":"N Engl J Med"},{"key":"664_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/mds.20319","volume":"20","author":"C Sato","year":"2005","unstructured":"Sato C, Morgan A, Lang AE, Salehi-Rad S, Kawarai T, Meng Y, Ray PN, Farrer LA, St George-Hyslop P, Rogaeva E: Analysis of the glucocerebrosidase gene in Parkinson\u2019s disease. Mov Disord. 2005, 20: 367-370.","journal-title":"Mov Disord"},{"key":"664_CR41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJM200502173520719","volume":"352","author":"MG Schlossmacher","year":"2005","unstructured":"Schlossmacher MG, Cullen V, Muthing J: The glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med. 2005, 352: 728-731. author reply 728\u2013731.","journal-title":"N Engl J Med"},{"key":"664_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymgme.2004.11.007","volume":"84","author":"E Sidransky","year":"2005","unstructured":"Sidransky E: Gaucher disease and parkinsonism. Mol Genet Metab. 2005, 84: 302-304.","journal-title":"Mol Genet Metab"},{"key":"664_CR43","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJM200502173520719","volume":"352","author":"A Zimran","year":"2005","unstructured":"Zimran A, Neudorfer O, Elstein D: The glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med. 2005, 352: 728-731. author reply 728\u2013731.","journal-title":"N Engl J Med"},{"key":"664_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neulet.2006.05.032","volume":"404","author":"MJ Eblan","year":"2006","unstructured":"Eblan MJ, Scholz S, Stubblefield B, Gutti U, Goker-Alpan O, Hruska KS, Singleton AB, Sidransky E: Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism. Neurosci Lett. 2006, 404: 163-165.","journal-title":"Neurosci Lett"},{"key":"664_CR45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","volume":"67","author":"O Goker-Alpan","year":"2006","unstructured":"Goker-Alpan O, Giasson BI, Eblan MJ, Nguyen J, Hurtig HI, Lee VM, Trojanowski JQ, Sidransky E: Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology. 2006, 67: 908-910.","journal-title":"Neurology"},{"key":"664_CR46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2169\/internalmedicine.45.1790","volume":"45","author":"K Itokawa","year":"2006","unstructured":"Itokawa K, Tamura N, Kawai N, Shimazu K, Ishii K: Parkinsonism in type I Gaucher\u2019s disease. Intern Med. 2006, 45: 1165-1167.","journal-title":"Intern Med"},{"key":"664_CR47","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/jnnp.2005.076240","volume":"77","author":"M Spitz","year":"2006","unstructured":"Spitz M, Rozenberg R, Silveira PA, Barbosa ER: Parkinsonism in type 1 Gaucher\u2019s disease. J Neurol Neurosurg Psychiatry. 2006, 77: 709-710.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"664_CR48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/01.wnl.0000276989.17578.02","volume":"69","author":"LN Clark","year":"2007","unstructured":"Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, et al: Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 2007, 69: 1270-1277.","journal-title":"Neurology"},{"key":"664_CR49","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/archneur.64.7.1056","volume":"64","author":"EK Tan","year":"2007","unstructured":"Tan EK, Tong J, Fook-Chong S, Yih Y, Wong MC, Pavanni R, Zhao Y: Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch Neurol. 2007, 64: 1056-1058.","journal-title":"Arch Neurol"},{"key":"664_CR50","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","volume":"65","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E: The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol. 2008, 65: 1353-1357.","journal-title":"Arch Neurol"},{"key":"664_CR51","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archneurol.2009.72","volume":"66","author":"J Mitsui","year":"2009","unstructured":"Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J, Fukuda Y, Date H, Iwata A, Yamamoto M, et al: Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol. 2009, 66: 571-576.","journal-title":"Arch Neurol"},{"key":"664_CR52","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1212\/WNL.0b013e3181b28601","volume":"73","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Samaddar T, Tayebi N: Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology. 2009, 73: 1424-1425. author reply 1425\u20131426.","journal-title":"Neurology"},{"key":"664_CR53","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, et al: Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med. 2009, 361: 1651-1661.","journal-title":"N Engl J Med"},{"key":"664_CR54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1212\/WNL.0b013e318207b01e","volume":"76","author":"S Lesage","year":"2011","unstructured":"Lesage S, Condroyer C, Hecham N, Anheim M, Belarbi S, Lohman E, Viallet F, Pollak P, Abada M, Durr A, et al: Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa. Neurology. 2011, 76: 301-303.","journal-title":"Neurology"},{"key":"664_CR55","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/hmg\/ddq454","volume":"20","author":"S Lesage","year":"2011","unstructured":"Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C, Viallet F, Lohmann E, Corvol JC, Honore A, et al: Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease. Hum Mol Genet. 2011, 20: 202-210.","journal-title":"Hum Mol Genet"},{"key":"664_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/35006074","volume":"404","author":"MB Feany","year":"2000","unstructured":"Feany MB, Bender WW: A Drosophila model of Parkinson\u2019s disease. Nature. 2000, 404: 394-398.","journal-title":"Nature"},{"key":"664_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2183\/pjab.88.18","volume":"88","author":"S Ishii","year":"2012","unstructured":"Ishii S: Pharmacological chaperone therapy for Fabry disease. Proc Jpn Acad Ser B Phys Biol Sci. 2012, 88: 18-30.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"664_CR58","doi-asserted-by":"publisher","first-page":"C1076","DOI":"10.1152\/ajpcell.00426.2005","volume":"290","author":"GH Yam","year":"2006","unstructured":"Yam GH, Bosshard N, Zuber C, Steinmann B, Roth J: Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. Am J Physiol Cell Physiol. 2006, 290: C1076-C1082.","journal-title":"Am J Physiol Cell Physiol"},{"key":"664_CR59","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000316540","volume":"8","author":"A Klein","year":"2011","unstructured":"Klein A, Mosqueira M, Martinez G, Robledo F, Gonzalez M, Caballero B, Cancino GI, Alvarez AR, Hetz C, Zanlungo S: Lack of activation of the unfolded protein response in mouse and cellular models of Niemann-Pick type C disease. Neurodegener Dis. 2011, 8: 124-128.","journal-title":"Neurodegener Dis"},{"key":"664_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D: Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell. 2011, 146: 37-52.","journal-title":"Cell"},{"key":"664_CR61","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/archneurol.2009.54","volume":"66","author":"LN Clark","year":"2009","unstructured":"Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, et al: Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol. 2009, 66: 578-583.","journal-title":"Arch Neurol"},{"key":"664_CR62","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.22400","volume":"69","author":"V Cullen","year":"2011","unstructured":"Cullen V, Sardi SP, Ng J, Xu YH, Sun Y, Tomlinson JJ, Kolodziej P, Kahn I, Saftig P, Woulfe J, et al: Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing. Ann Neurol. 2011, 69: 940-953.","journal-title":"Ann Neurol"},{"key":"664_CR63","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, Dawson TM: PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson\u2019s disease. Cell. 2011, 144: 689-702.","journal-title":"Cell"},{"key":"664_CR64","doi-asserted-by":"publisher","first-page":"e38837","DOI":"10.1371\/journal.pone.0038837","volume":"7","author":"S Kemeny","year":"2012","unstructured":"Kemeny S, Dery D, Loboda Y, Rovner M, Lev T, Zuri D, Finberg JP, Larisch S: Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein. PLoS One. 2012, 7: e38837.","journal-title":"PLoS One"},{"key":"664_CR65","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00018-012-1043-0","volume":"69","author":"D Lindholm","year":"2012","unstructured":"Lindholm D, Eriksson O, Makela J, Belluardo N, Korhonen L: PGC-1alpha: a master gene that is hard to master. Cell Mol Life Sci. 2012, 69: 2465-2468.","journal-title":"Cell Mol Life Sci"},{"key":"664_CR66","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/35046566","volume":"2","author":"S Larisch","year":"2000","unstructured":"Larisch S, Yi Y, Lotan R, Kerner H, Eimerl S, Tony Parks W, Gottfried Y, Birkey Reffey S, de Caestecker MP, Danielpour D, et al: A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nat Cell Biol. 2000, 2: 915-921.","journal-title":"Nat Cell Biol"},{"key":"664_CR67","first-page":"90","volume":"232C","author":"I Lonskaya","year":"2012","unstructured":"Lonskaya I, Hebron ML, Algarzae NK, Desforges N, Moussa CE: Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson\u2019s disease. Neuroscience. 2012, 232C: 90.","journal-title":"Neuroscience"},{"key":"664_CR68","doi-asserted-by":"publisher","first-page":"12101","DOI":"10.1073\/pnas.1108197108","volume":"108","author":"SP Sardi","year":"2011","unstructured":"Sardi SP, Clarke J, Kinnecom C, Tamsett TJ, Li L, Stanek LM, Passini MA, Grabowski GA, Schlossmacher MG, Sidman RL, et al: CNS expression of glucocerebrosidase corrects {alpha}-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc Natl Acad Sci USA. 2011, 108: 12101-12106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"664_CR69","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","volume":"102","author":"YH Xu","year":"2011","unstructured":"Xu YH, Sun Y, Ran H, Quinn B, Witte D, Grabowski GA: Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models. Mol Genet Metab. 2011, 102: 436-447.","journal-title":"Mol Genet Metab"},{"key":"664_CR70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000335038","volume":"10","author":"SP Sardi","year":"2012","unstructured":"Sardi SP, Singh P, Cheng SH, Shihabuddin LS, Schlossmacher MG: Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models. Neurodegener Dis. 2012, 10: 195-202.","journal-title":"Neurodegener Dis"},{"key":"664_CR71","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1073\/pnas.1220464110","volume":"110","author":"SP Sardi","year":"2013","unstructured":"Sardi SP, Clarke J, Viel C, Chan M, Tamsett TJ, Treleaven CM, Bu J, Sweet L, Passini MA, Dodge JC, et al: Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc Natl Acad Sci USA. 2013, 110: 3537-3542.","journal-title":"Proc Natl Acad Sci USA"},{"key":"664_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","volume":"107","author":"Z Zheng","year":"2012","unstructured":"Zheng Z, Diamond MI: Huntington disease and the huntingtin protein. Prog Mol Biol Transl Sci. 2012, 107: 189-214.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"664_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","volume":"122","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Holton JL, Revesz T, Dickson DW: Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol. 2011, 122: 187-204.","journal-title":"Acta Neuropathol"},{"key":"664_CR74","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/syn.20957","volume":"65","author":"P Seeman","year":"2011","unstructured":"Seeman P, Seeman N: Alzheimer\u2019s disease: beta-amyloid plaque formation in human brain. Synapse. 2011, 65: 1289-1297.","journal-title":"Synapse"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-8-140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:52:39Z","timestamp":1630547559000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-8-140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,11]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-8-140","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,11]]},"assertion":[{"value":"5 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"140"}}